Navigation Links
Researchers ID Traits of Aggressive Prostate Cancer
Date:6/13/2008

Findings could lead to diagnostic urine test for 10% of men with the disease

FRIDAY, June 13 (HealthDay News) -- The traits of an aggressive type of prostate cancer that occurs in about 10 percent of men with the disease have been identified in hopes of finding a way to diagnose it early, according to researchers.

A team at the Michigan Center for Translational Pathology at the University of Michigan Health System found excess amounts of a gene called SPINK1 (serine peptidase inhibitor, Kazal type 1) in prostate cancers that do not have gene fusions of unrelated cells, a condition that plays a role in at least 50 percent of prostate cancer cases. This led them to believe that SPINK1 is a biomarker -- a molecule in bodily fluids, blood and tissue that can be a signal of a disease -- for a subtype of prostate cancer.

"Because SPINK1 can be found non-invasively in urine, a test could be developed that would complement current urine testing that is used to detect some prostate cancer or future urine tests for gene fusions," Dr. Arul Chinnaiyan, the center's director and senior author of the study, said in a prepared statement.

The findings, published in the June issue of Cancer Cell, also suggest that men with SPINK1-related prostate cancers tend to experience a recurrence of the disease faster than those with other types of prostate cancer.

The discovery came from the researchers analyzing data on 1,800 prostate cancers in search of common pieces of their genetic aberrations.

The National Cancer Institute estimates that this year, 186,320 new cases of prostate cancer will be diagnosed, and more than 28,000 men will die from the disease.

More information

The National Cancer Institute has more about prostate cancer.



-- Kev
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
4. Bipolar disorder relapses halved by Melbourne researchers
5. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
6. High and mighty: first common height gene identified by researchers behind obesity gene finding
7. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
8. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
9. Researchers develop long-lasting growth hormone
10. Jefferson immunology researchers halt lethal rabies infection in brain
11. Purdue researchers develop technology to detect cancer by scanning surface veins
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Ascension Orthopedics Hires Key Senior Executives 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6ER Doctor Demonstrates Breast Pump on Live TV with Patented New Freemie Hands Free System 14040 1ER Doctor Demonstrates Breast Pump on Live TV with Patented New Freemie Hands Free System 14040 2ER Doctor Demonstrates Breast Pump on Live TV with Patented New Freemie Hands Free System 14040 3ER Doctor Demonstrates Breast Pump on Live TV with Patented New Freemie Hands Free System 14040 4Clalit Health Services Installs DBSophic 26apos 3Bs Database Performance Optimization Solution 57144 1Clalit Health Services Installs DBSophic 26apos 3Bs Database Performance Optimization Solution 57144 2Clalit Health Services Installs DBSophic 26apos 3Bs Database Performance Optimization Solution 57144 3Clalit Health Services Installs DBSophic 26apos 3Bs Database Performance Optimization Solution 57144 4STEMCELL Technologies Applauds Feeder free Derivation of Human Induced Pluripotent Stem Cells 57142 1STEMCELL Technologies Applauds Feeder free Derivation of Human Induced Pluripotent Stem Cells 57142 2